npj Breast Cancer, 2374-4677

Journal

More filtering options
  1. 2020
  2. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

    Hudeček, J., Horlings, H. M., International Immuno-Oncology Biomarker Working Group & Anna Ehinger, 2020 May 12, In : npj Breast Cancer. 6, 1, 15.

    Research output: Contribution to journalReview article

  3. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Kos, Z., Roblin, E., Kim, R. S., Michiels, S., Gallas, B. D., Chen, W., van de Vijver, K. K., Goel, S., Adams, S., Demaria, S., Viale, G., Nielsen, T. O., Badve, S. S., Symmans, W. F., Sotiriou, C., Rimm, D. L., Hewitt, S., Denkert, C., Loibl, S., Ehinger, A. & 1 others, Salgado, R., 2020 May 12, In : npj Breast Cancer. 6, 17.

    Research output: Contribution to journalArticle

  4. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Amgad, M., Cooper, L. A. D., International Immuno-Oncology Biomarker Working Group & Anna Ehinger, 2020 May 12, In : npj Breast Cancer. 6, 16, 16.

    Research output: Contribution to journalArticle

  5. 2019
  6. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    Figlioli, G., Hermann Brenner, Carolina Ellberg, Hall, P., Håkan Olsson, Peterlongo, P., ABCTB Investigators, GEMO Study Collaborators & KConFab Investigators, 2019, In : npj Breast Cancer. 5, 1, 38.

    Research output: Contribution to journalArticle